XRP News Today: XRP ETFs Offer Long-Term Optimism Amid Intensifying Short-Term Downtrend
- XRP price fell below $2 despite new spot ETFs, with open interest hitting November 2024 lows amid crypto outflows and bearish sentiment. - Bitwise and 21Shares launched XRP ETFs, but $22M first-day volume failed to offset 7% price drop and whale-driven selling of 200M tokens. - SEC approvals enabled ETFs from Franklin Templeton/Grayscale, yet derivatives data shows $473M Binance open interest decline and negative funding rates. - Analysts note ETFs could attract institutional capital long-term, but short
The
Bitwise and 21Shares have joined other companies in rolling out spot XRP ETFs in the United States, with Bitwise’s fund
After a lengthy period of regulatory uncertainty,
From a technical perspective, XRP has not managed to recover crucial support levels, with its price
Ripple’s investments in infrastructure and its $1 billion treasury initiative have sparked some optimism, but these moves have not yet counteracted the immediate selling pressure.
Although the short-term outlook is still unclear, some market watchers think the ETFs could set the stage for future capital inflows. "
At present, XRP traders are navigating a challenging environment, balancing short-term bearish trends with the potential for longer-term growth. With open interest at multi-year lows and funding rates in negative territory, the market is preparing for either continued consolidation or a significant move.
---
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
PetVivo's transition to AI-powered SaaS disrupts MedTech valuations, aiming for a 15-fold growth
- PetVivo launched PetVivo.ai, an AI platform slashing veterinary client acquisition costs by 90% through automated lead generation and engagement. - The platform cuts costs to $42.53 (vs. $80–$400) and enables 80–90% gross margins, shifting the company from low-margin medical devices to a SaaS model. - With 12 patents, 1,200 distributors, and $360M 5-year ARR projections, PetVivo aims to re-rate its valuation from 1–2x to 15x revenue multiples like C3.ai.

Astar (ASTR) Price Rally: How Cross-Chain Blockchain Solutions Attract Institutional Interest
- Astar (ASTR) gains institutional traction as blockchain interoperability drives adoption, with $3.16M investment in October 2025. - Technical upgrades like Astar 2.0's 150,000 TPS capacity and partnerships with Sony/Japan Airlines enhance cross-chain utility. - Q3 2025 TVL of $2.38M contrasts with DeFi's $11.96B decline, highlighting Astar's deflationary tokenomics and institutional appeal. - Strategic positioning as a multichain bridge validates ASTR's role in connecting traditional finance with decentr

DOGE Builds 12h Wedge as Chart Signals an 80 to 90% Upside Zone

XLM Tracks 51 and 52 Bar Cycles With Price Near $0.618 and $0.786 Zones
